Bayer hit with $2 billion Roundup verdict in US state of Georgia cancer case Bayer was ordered by a jury in the U.S. state of Georgia to pay about $2.1 billion to a plaintiff who claimed the ...

Bayer's move leaves Merck still out in front – with an approval for gefapixant for cough in Japan where the drug is known as Lyfnua – but clearly casts a shadow on the class as a whole.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

European Union leaders said on Thursday that they will continue to support Ukraine, but they did not immediately endorse a call by Ukrainian President Volodymyr Zelenskiy to provide at least 5 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA ...

Discover for yourself - whether privately or on business - the first-class service at Bayer 04 Leverkusen and become part of the club under the Bayer Cross. Versatile, multifunctional: in the BayArena ...